| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011683853 |
| P356 | DOI | 10.1186/1742-4690-3-89 |
| P932 | PMC publication ID | 1697824 |
| P698 | PubMed publication ID | 17144911 |
| P5875 | ResearchGate publication ID | 6653988 |
| P50 | author | Jørgen Kjems | Q55277197 |
| Marianne Otte | Q57404647 | ||
| P2093 | author name string | Heiner Schaal | |
| Ilona Hauber | |||
| Joachim Hauber | |||
| Susanne Kammler | |||
| P2860 | cites work | Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function | Q79096514 |
| Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production | Q21245209 | ||
| HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. | Q24543241 | ||
| A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression | Q24563281 | ||
| Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end | Q24807291 | ||
| Extended base pair complementarity between U1 snRNA and the 5' splice site does not inhibit splicing in higher eukaryotes, but rather increases 5' splice site recognition | Q24812684 | ||
| A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication | Q25255588 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| CRM1 is an export receptor for leucine-rich nuclear export signals | Q27860453 | ||
| A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins | Q28246228 | ||
| In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32 | Q28278287 | ||
| Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion | Q28646837 | ||
| Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA | Q28646843 | ||
| CRM1 is responsible for intracellular transport mediated by the nuclear export signal | Q29547861 | ||
| ESEfinder: A web resource to identify exonic splicing enhancers | Q29616126 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| Exon Identity Established through Differential Antagonism between Exonic Splicing Silencer-Bound hnRNP A1 and Enhancer-Bound SR Proteins | Q30040281 | ||
| Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1 | Q30450216 | ||
| Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus | Q33562331 | ||
| The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly | Q33778676 | ||
| U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced | Q33821654 | ||
| Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. | Q33824324 | ||
| Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors | Q33853846 | ||
| RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element | Q33854295 | ||
| An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication | Q33911993 | ||
| A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H. | Q33954292 | ||
| SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing | Q33974928 | ||
| SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain. | Q34092879 | ||
| Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing | Q34260427 | ||
| The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA. | Q34363471 | ||
| Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor | Q34365986 | ||
| Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. | Q34626299 | ||
| The retrovirus RNA trafficking granule: from birth to maturity | Q34667412 | ||
| Mechanism of HIV-1 viral protein R-induced apoptosis | Q35120771 | ||
| Three recognition events at the branch-site adenine. | Q35846398 | ||
| Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression | Q35880472 | ||
| The spliceosome: a novel multi-faceted target for therapy | Q36189908 | ||
| Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing | Q36384842 | ||
| Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. | Q36554047 | ||
| Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors | Q36554054 | ||
| Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. | Q36633363 | ||
| Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. | Q36654112 | ||
| Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression | Q36687102 | ||
| Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns | Q36695561 | ||
| Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 | Q36806618 | ||
| Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages | Q36810554 | ||
| A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation | Q37635903 | ||
| Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements | Q39444777 | ||
| The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element. | Q39645951 | ||
| SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. | Q39646678 | ||
| A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production | Q39882220 | ||
| A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability | Q40283703 | ||
| A novel approach to describe a U1 snRNA binding site. | Q40315328 | ||
| Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. | Q41271968 | ||
| Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein | Q41657615 | ||
| hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing | Q41679293 | ||
| Regulation by HIV Rev depends upon recognition of splice sites | Q41758926 | ||
| hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure | Q42621995 | ||
| The D1-A2 and D2-A2 pairs of splice sites from human immunodeficiency virus type 1 are highly efficient in vitro, in spite of an unusual branch site | Q45761048 | ||
| The HIV 'A' (sor) gene product is essential for virus infectivity | Q45847960 | ||
| Use of DNA end joining activity of a Xenopus laevis egg extract for construction of deletions and expression vectors for HIV-1 Tat and Rev proteins | Q49152914 | ||
| A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding. | Q52548171 | ||
| Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs | Q71020737 | ||
| Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro | Q71823431 | ||
| Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs | Q77678068 | ||
| P304 | page(s) | 89 | |
| P577 | publication date | 2006-12-04 | |
| P1433 | published in | Retrovirology | Q15793508 |
| P1476 | title | The strength of the HIV-1 3' splice sites affects Rev function | |
| P478 | volume | 3 |
| Q38961890 | A functional conserved intronic G run in HIV-1 intron 3 is critical to counteract APOBEC3G-mediated host restriction. |
| Q90218662 | A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importance |
| Q37677066 | Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action |
| Q39222999 | An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA. |
| Q38705930 | Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b |
| Q35575811 | Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication |
| Q50176880 | Behind the scenes of HIV-1 replication: Alternative splicing as the dependency factor on the quiet. |
| Q39194586 | Can the HIV-1 splicing machinery be targeted for drug discovery? |
| Q37584186 | Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication |
| Q34671913 | Comparison of SIV and HIV-1 genomic RNA structures reveals impact of sequence evolution on conserved and non-conserved structural motifs |
| Q35261679 | Converging strategies in expression of human complex retroviruses |
| Q34169373 | Correct mRNA processing at a mutant TT splice donor in FANCC ameliorates the clinical phenotype in patients and is enhanced by delivery of suppressor U1 snRNAs. |
| Q35143725 | Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy |
| Q92071667 | Expression Level of HIV-1 Vif Can Be Fluctuated by Natural Nucleotide Variations in the vif-Coding and Regulatory SA1D2prox Sequences of the Proviral Genome |
| Q37152994 | Extensive purifying selection acting on synonymous sites in HIV-1 Group M sequences |
| Q36479939 | Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins |
| Q34249488 | Genomic HEXploring allows landscaping of novel potential splicing regulatory elements. |
| Q47548285 | Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication. |
| Q37323917 | HIV-1 Vpr N-terminal tagging affects alternative splicing of the viral genome |
| Q41591221 | Heterogenous nuclear ribonucleoprotein Q increases protein expression from HIV-1 Rev-dependent transcripts |
| Q39790727 | Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein |
| Q43029724 | Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer |
| Q39783741 | Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure |
| Q64072075 | Modulation of HIV-1 gene expression by binding of a ULM motif in the Rev protein to UHM-containing splicing factors |
| Q33565157 | Multi-Faceted Post-Transcriptional Functions of HIV-1 Rev. |
| Q36811895 | Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels |
| Q37713854 | Natural single-nucleotide polymorphisms in the 3' region of the HIV-1 pol gene modulate viral replication ability |
| Q36540041 | Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression |
| Q36481243 | Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms. |
| Q47554842 | Production of HIV-1 vif mRNA Is Modulated by Natural Nucleotide Variations and SLSA1 RNA Structure in SA1D2prox Genomic Region |
| Q52423047 | Programmable design of functional ribonucleoprotein complexes. |
| Q35079162 | Rev-ing up post-transcriptional HIV-1 RNA expression |
| Q42247651 | Stable assembly of HIV-1 export complexes occurs cotranscriptionally. |
| Q38286131 | The HIV-1 Tat protein has a versatile role in activating viral transcription |
| Q45219002 | The HIV-1 major splice donor D1 is activated by splicing enhancer elements within the leader region and the p17-inhibitory sequence |
| Q36515503 | The impact of multiple splice sites in human L1 elements |
| Q36368449 | The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture |
| Q36607087 | Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA |
| Q34030804 | Transcriptional and posttranscriptional regulation of HIV-1 gene expression |
| Q37349210 | Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses |
Search more.